1342321

Insulinlispro

United States Pharmacopeia (USP) Reference Standard

• Empirische Formel (Hill-System): C₂₅₇H₃₈₃N₆₅O₇₇S₆
• CAS-Nummer: 133107-64-9
• Molekulargewicht: 5807.57
• MDL-Nummer: MFCD01773207
• UNSPSC-Code: 41116107
• NACRES: NA.24

Eigenschaften

• Qualität: pharmaceutical primary standard
• API-Familie: insulin
• Hersteller/Markenname: USP
• Anwendung(en): pharmaceutical (small molecule)
• Format: neat
• Lagertemp.: −20°C
• InChIKey: WNRQPCUGRUFHED-DETKDSODSA-N

Beschreibung

Allgemeine Beschreibung

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Insulin lispro is a type of insulin that is structurally very similar to Insulin Human, except for the arrangement of amino acids at positions 28 and 29 of the B-chain, where lysine and proline are found. Insulin Lispro is manufactured using recombinant DNA technology.

Anwendung

Insulin lispro USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as:

• Insulin Lispro Injection

Hinweis zur Analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Sonstige Hinweise

This product is part of the USP Biologics program.

Sales restrictions may apply.

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable